Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

HKSE 2196.HK

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Net Income Margin for the year ending December 31, 2023: 5.76%

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Net Income Margin is 5.76% for the year ending December 31, 2023, a -32.10% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Net Income Margin for the year ending December 31, 2022 was 8.49%, a -29.98% change year over year.
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Net Income Margin for the year ending December 31, 2021 was 12.12%, a 0.31% change year over year.
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Net Income Margin for the year ending December 31, 2020 was 12.09%, a 4.01% change year over year.
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Net Income Margin for the year ending December 31, 2019 was 11.62%, a 6.93% change year over year.
Key data
Date Net Income Margin EBITDA Margin EBIT Margin EBITDA
Market news
SV Wall Street
HKSE: 2196.HK

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

CEO Mr. Deyong Wen
IPO Date Oct. 30, 2012
Location China
Headquarters Building A
Employees 40,370
Sector Healthcare
Industries
Pharmaceuticals Biotechnology Cosmetics Dental Care Drugstores & Retail Pharmacies Medical Instruments Personal Care
Description

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, metabolism, alimentary and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.

Similar companies

2607.HK

Shanghai Pharmaceuticals Holding Co., Ltd

USD 1.57

-1.09%

1099.HK

Sinopharm Group Co. Ltd.

USD 2.56

-3.26%

StockViz Staff

February 8, 2025

Any question? Send us an email